Dr. Pankaj Singla currently holds the position of a Research Associate at the University of Manchester. Prior to this role, he served as an MSCA (Marie Skłodowska-Curie Actions) individual fellow at the School of Engineering, Newcastle University. Dr. Singla earned his Masters in Pharmaceutical Chemistry and subsequently pursued his PhD in the same field in India. During his doctoral studies, he embarked on a 5-month research visit at Manchester Metropolitan University, UK, supported by the Newton-Bhaba PhD placement fellowship.

His research focus has centered around the intricate realm of drug delivery, particularly exploring the utilization of nanoparticles for delivering various therapeutic agents. Following the successful completion of his PhD in April 2020, Dr. Singla's exceptional work led to his selection for the prestigious MSCA individual fellowship later that same year. In April 2021, he joined Prof Peeters' lab at the School of Engineering, Newcastle University, UK, to spearhead his MSCA project.

Dr. Singla has been actively engaged in ongoing research within the same group, concentrating on the development of polymeric nanostructures. These structures are designed for efficient drug delivery to combat cancer, with a specific focus on cancer therapeutics and diagnostics. Leveraging Molecular imprinting technology, he aims to contribute significantly to the advancement of targeted and effective cancer treatments.